|
| Press Releases |
|
 |
|
| Tuesday, December 15, 2020 |
|
|
德琪醫藥中長線價值俱佳 未來兩年陸續收成 |
| 中國生物科技股行業前景佳，市場對創新醫藥的需求隨著醫療服務質量的持續提升而擴大，尤其在抗腫瘤及免疫系統相關治療領域，未來市場新增需求更有望迎來黃金機遇。 more info >> |
|
| Friday, November 20, 2020 |
|
|
覆蓋亞太地區的一體化創新腫瘤藥公司德琪醫藥有限公司於香港聯合交易所主板掛牌 |
| 德琪醫藥有限公司（「德琪醫藥」或「公司」，連同其附屬公司，統稱「集團」；股份代號：6996.HK），一家面向亞太、佈局全球，集新藥開發、臨床研究於一體的臨床階段生物醫藥公司，今天於香港聯合交易所有限公司（「港交所」）主板正式掛牌並開始交易。 more info >> |
|
|
Antengene Corporation Successfully Listed on Main Board of SEHK |
| Antengene Corporation Limited ("Antengene" or the "Company", together with its subsidiaries, the "Group", stock code: 6996.HK), a clinical-stage biopharmaceutical company with integrated drug discovery, clinical development, anchored in Asia-Pacific (APAC) with a global layout, is officially listed and commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") today. more info >> |
|
| Monday, July 20, 2020 |
|
|
德琪醫藥C輪融資9700萬美元，主要用於新藥研發和商業化 |
| 專注於研發和商業化腫瘤領域全新機制及同類最優創新藥的領導企業——德琪醫藥，今日宣佈完成9700萬美元C輪融資。 more info >> |
|
|
德琪医药C轮融资9700万美元，主要用于新药研发和商业化 |
| 专注于研发和商业化肿瘤领域全新机制及同类最优创新药的领导企业——德琪医药，今日宣布完成9700万美元C轮融资。 more info >> |
|
|
Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization |
| Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
エーザイ、「健康経営銘柄2025」に初選定
Mar 10, 2025 15:45: JST
|
|
|
The PropertyGuru Asia Awards Malaysia in Partnership with iProperty return with 23 new categories in 2025
Mar 10, 2025 14:00 HKT/SGT
|
|
|
World's Most Sleep-Deprived Nation Has a Gender Crisis: Why Singaporean Women Bear the Heaviest Burden
Mar 10, 2025 13:00 HKT/SGT
|
|
|
Hola Prime to Introduce Prime Academy for Personalized Trader Mentorship
Mar 10, 2025 13:00: JST
|
|
|
uSMART Securities Surges 300% in Hong Kong Local Users
Mar 10, 2025 12:28 HKT/SGT
|
|
|
盈立證券激增300%香港本地用戶 開設2家新分行 搶佔市場份額
Mar 10, 2025 12:14 HKT/SGT
|
|
|
Hola Prime to Introduce Prime Academy for Personalized Trader Mentorship
Mar 10, 2025 12:00 HKT/SGT
|
|
|
マツダ、「AUTOMOBILE COUNCIL 2025」に出展
Mar 10, 2025 12:00: JST
|
|
|
盈立证券激增300%香港本地用户 开设2家新分行 抢占市场份额
Mar 10, 2025 11:51 HKT/SGT
|
|
|
珠宝双展匯聚逾82,000环球买家
Mar 9, 2025 13:51 HKT/SGT
|
|
|
珠寶雙展匯聚逾82,000環球買家
Mar 9, 2025 13:41 HKT/SGT
|
|
|
Twin jewellery shows attract over 82,000 global buyers
Mar 9, 2025 13:19 HKT/SGT
|
|
|
OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million
Mar 8, 2025 19:40 HKT/SGT
|
|
|
Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation
Mar 8, 2025 19:20 HKT/SGT
|
|
|
uSMART Securities Initiates Coverage on NAAS Technology with a 'Buy' Rating and a Target Price of US$3.2 per ADS, Citing Industry Leadership and Profitability Outlook
Mar 7, 2025 21:26: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
